Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study
- Resource Type
- Article
- Source
- In
Digestive and Liver Disease November 2023 - Subject
- Language
- ISSN
- 1590-8658